Oragenics Inc (OGEN)
0.274
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.2809
+0.01
(+2.52%)
After-Hours: 20:00
Oragenics Cash from Financing (Quarterly): 3.766M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.766M |
| June 30, 2024 | 0.8212M |
| March 31, 2024 | 1.653M |
| December 31, 2023 | -0.1806M |
| September 30, 2023 | 0.7321M |
| June 30, 2023 | -0.1079M |
| March 31, 2023 | -0.1598M |
| December 31, 2022 | -0.088M |
| September 30, 2022 | -0.1035M |
| June 30, 2022 | -0.1222M |
| March 31, 2022 | -0.1812M |
| December 31, 2021 | -0.1788M |
| September 30, 2021 | -0.0219M |
| June 30, 2021 | 0.1523M |
| March 31, 2021 | 23.19M |
| December 31, 2020 | 11.23M |
| September 30, 2020 | 5.080M |
| June 30, 2020 | 0.0897M |
| March 31, 2020 | -0.073M |
| December 31, 2019 | -0.0736M |
| September 30, 2019 | -0.05M |
| June 30, 2019 | -0.13M |
| March 31, 2019 | 11.35M |
| December 31, 2018 | 9.439M |
| September 30, 2018 | 12.39M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.464M |
| March 31, 2018 | -0.0416M |
| December 31, 2017 | 4.602M |
| September 30, 2017 | 2.174M |
| June 30, 2017 | 1.679M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | 0.9394M |
| September 30, 2016 | 0.9499M |
| June 30, 2016 | 2.596M |
| March 31, 2016 | -0.0339M |
| December 31, 2015 | -0.0462M |
| September 30, 2015 | -0.0343M |
| June 30, 2015 | -0.0446M |
| March 31, 2015 | -0.0348M |
| December 31, 2014 | -0.0447M |
| September 30, 2014 | -0.0345M |
| June 30, 2014 | -0.0446M |
| March 31, 2014 | -0.0344M |
| December 31, 2013 | 9.229M |
| September 30, 2013 | 3.876M |
| June 30, 2013 | 0.0238M |
| March 31, 2013 | 0.0053M |
| December 31, 2012 | -0.0798M |
| September 30, 2012 | 11.81M |
| June 30, 2012 | 1.312M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1812M
Minimum
Mar 2022
23.19M
Maximum
Mar 2021
2.271M
Average
-0.0475M
Median
Cash from Financing (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -0.1968M |
| Alaunos Therapeutics Inc | 0.00 |
| SELLAS Life Sciences Group Inc | 19.69M |
| Galectin Therapeutics Inc | 10.00M |
| Anavex Life Sciences Corp | 4.55M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.970M |
| Free Cash Flow | -7.682M |
| Free Cash Flow Per Share (Quarterly) | -0.3018 |
| Free Cash Flow Yield | -654.1% |